Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.530 USD | -5.03% | -2.79% | -25.62% |
Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Revenues | 1.83B | 4.02B | 3.58B | 2.8B | 2.7B | |||
Other Revenues, Total | - | - | -100K | - | - | |||
Total Revenues | 1.83B | 4.02B | 3.58B | 2.8B | 2.7B | |||
Cost of Goods Sold, Total | 989M | 2.57B | 2.88B | 1.88B | 1.49B | |||
Gross Profit | 837M | 1.45B | 698M | 924M | 1.21B | |||
Selling General & Admin Expenses, Total | 768M | 1.33B | 1.86B | 1.34B | 1.3B | |||
R&D Expenses | 89M | 248M | 360M | 318M | 305M | |||
Other Operating Expenses, Total | 857M | 1.58B | 2.22B | 1.66B | 1.6B | |||
Operating Income | -20.5M | -126M | -1.52B | -738M | -398M | |||
Interest Expense, Total | - | -14.8M | -43M | -97.1M | -112M | |||
Interest And Investment Income | 16.2M | 7.9M | 2.3M | 26.4M | 35.1M | |||
Net Interest Expenses | 16.2M | -6.9M | -40.7M | -70.7M | -77.4M | |||
Currency Exchange Gains (Loss) | -4M | -3.5M | -31.8M | 7M | - | |||
Other Non Operating Income (Expenses) | 400K | 0 | -1.4M | 2.7M | 800K | |||
EBT, Excl. Unusual Items | -7.9M | -136M | -1.59B | -799M | -474M | |||
Restructuring Charges | - | - | -554M | -329M | -107M | |||
Merger & Related Restructuring Charges | -300K | -26.5M | -5.5M | - | - | |||
Impairment of Goodwill | - | - | -182M | - | - | |||
Asset Writedown | - | - | -16.7M | -5.2M | -16.5M | |||
Legal Settlements | -60.1M | -35.8M | -119M | -103M | -10.8M | |||
Other Unusual Items | - | - | -338M | -22M | 56.2M | |||
EBT, Incl. Unusual Items | -68.3M | -198M | -2.81B | -1.26B | -552M | |||
Income Tax Expense | 3.3M | -9.2M | 19.6M | 3.7M | -200K | |||
Earnings From Continuing Operations | -71.6M | -189M | -2.83B | -1.26B | -552M | |||
Net Income to Company | -71.6M | -189M | -2.83B | -1.26B | -552M | |||
Net Income - (IS) | -71.6M | -189M | -2.83B | -1.26B | -552M | |||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||
Net Income to Common Incl Extra Items | -71.6M | -189M | -2.83B | -1.26B | -552M | |||
Net Income to Common Excl. Extra Items | -71.6M | -189M | -2.83B | -1.26B | -552M | |||
Per Share Items | ||||||||
Net EPS - Basic | -0.32 | -0.64 | -8.77 | -3.64 | -1.51 | |||
Basic EPS - Continuing Operations | -0.32 | -0.64 | -8.77 | -3.64 | -1.51 | |||
Basic Weighted Average Shares Outstanding | 221M | 294M | 322M | 347M | 366M | |||
Net EPS - Diluted | -0.32 | -0.64 | -8.77 | -3.64 | -1.51 | |||
Diluted EPS - Continuing Operations | -0.32 | -0.64 | -8.77 | -3.64 | -1.51 | |||
Diluted Weighted Average Shares Outstanding | 221M | 294M | 322M | 347M | 366M | |||
Normalized Basic EPS | -0.02 | -0.29 | -3.09 | -1.44 | -0.81 | |||
Normalized Diluted EPS | -0.02 | -0.29 | -3.09 | -1.44 | -0.81 | |||
Supplemental Items | ||||||||
EBITDA | 12.9M | -70.4M | -1.4B | -652M | -332M | |||
EBITA | -15.4M | -106M | -1.48B | -722M | -387M | |||
EBIT | -20.5M | -126M | -1.52B | -738M | -398M | |||
EBITDAR | 103M | 52M | -1.23B | -532M | -231M | |||
Total Revenues (As Reported) | 1.83B | 4.02B | 3.58B | 2.8B | 2.7B | |||
Effective Tax Rate - (Ratio) | -4.83 | 4.64 | -0.7 | -0.29 | 0.04 | |||
Current Domestic Taxes | 1.2M | 400K | 1.3M | 600K | 800K | |||
Current Foreign Taxes | 3M | 11.5M | 13.6M | 4.6M | - | |||
Total Current Taxes | 4.2M | 11.9M | 14.9M | 5.2M | 800K | |||
Deferred Domestic Taxes | - | -17.3M | - | - | - | |||
Deferred Foreign Taxes | -900K | -3.8M | 4.7M | -1.5M | -1M | |||
Total Deferred Taxes | -900K | -21.1M | 4.7M | -1.5M | -1M | |||
Normalized Net Income | -4.94M | -84.94M | -996M | -500M | -296M | |||
Interest on Long-Term Debt | - | - | - | - | 110M | |||
Supplemental Operating Expense Items | ||||||||
Advertising Expense | 303M | 418M | 637M | 363M | 435M | |||
Selling and Marketing Expenses | 477M | 730M | 1.02B | 648M | 659M | |||
General and Administrative Expenses | 291M | 600M | 839M | 695M | 640M | |||
Research And Development Expense From Footnotes | 89M | 248M | 360M | 318M | 305M | |||
Net Rental Expense, Total | 89.9M | 122M | 167M | 120M | 101M | |||
Imputed Operating Lease Interest Expense | - | 14.09M | 29.64M | 39.49M | 40.84M | |||
Imputed Operating Lease Depreciation | - | 108M | 138M | 80.91M | 59.96M | |||
Stock-Based Comp., COGS (Total) | 10.7M | 38.5M | 42.9M | 57.1M | 49.5M | |||
Stock-Based Comp., R&D Exp. (Total) | 10.4M | 27.2M | 46M | 66.7M | 58.8M | |||
Stock-Based Comp., S&M Exp. (Total) | 15.3M | 26.2M | 30.5M | 28.9M | 19.7M | |||
Stock-Based Comp., G&A Exp. (Total) | 52.4M | 102M | 152M | 167M | 177M | |||
Stock-Based Comp., Other (Total) | - | - | 56.5M | 85.1M | 6.6M | |||
Total Stock-Based Compensation | 88.8M | 194M | 328M | 405M | 312M |